-unitedstates 18thcentury 1919- 1997h-324 1997i-061 1998a-922 2002m-334 2007i-050 2013g-035 2015l-337 20thcentury 614 active adjuvants administration adverseeffects allergyandimmunology anti-infectiveagents antigenes antigens antiparasiticagents approximately1772-approximately1826 asbestos attitudes autism biography biologicalavailability biologicalfactors biologicalproducts biologicalwarfare carbohydrates chemicalsynthesis chemistry chemotherapy child children communicablediseasecontrol communicablediseases compensation(law) complications computer-assisted congresses control coomunicablediseases cytokines damages databases decisionmaking design disabilityinsurance diseaseoutbreaks diseases dispositifs dissentanddisputes distribution dohmeinternational drugapproval drugdeliverysystems drugdesign drugdiscovery drugeffects drugindustry drugmonitoring economicaspects economics etc etiology genetic geneticengineering governmentpolicy healthaspects healthcommunication healthpolicy hilleman history historymerck host-parasiterelationships immunity immunization immunizationofchildren immunologic immunologicaladjuvants immunologicdeficiencysyndromes immunologists immunology immunotherapy infant ininfancy internationalcooperation isolation knowledge lawandlegislation lectins legislation malaria malariavaccine manuals massvaccination mauriceralph medical medicalsupplies medicaments medicine merck methodology methods military militarypersonnel models modern1601- molecularimmunology mouth mouthdiseases mucousmembrane mycobacterialdiseases organization pandemics parasiteantigens parasites patientsafety personalinjuries pharmaceutical pharmaceuticalindustry pharmaceuticaltechnology pharmacokinetics pharmacology physiology planning postmarketing prevention preventive preventivemedicine productsliability productsurveillance proteins psychology publichealth publicopinion publicpolicy qr189 qv241 qw39m368v2004 qw800 qw805 qw805a191v1997 qw805a425v2007 qw805i59142005 qw805i593a2012 qw805r5951997 qw805v1161985 qw805v11621997 qw805v116471996 qw806 qx4u171989p ra refusaltoparticipate research riskassessment riskfactors rm281 rs192 sabastiano safety safetymeasures sardinia science sebastiano sharp smallpoxvaccine socialvalues software standards supply synthetic syntheticvaccines technologicalinnovations technology theoretical therapeuticuse torts toxicology treatmentrefusal trends unitedstates unitedstatesgovernmentagencies vaccination vaccinationofchildren vaccinesindustry vaccins virology virulence virusdiseases viruses w3in181w3rd1985aqw504i59171985a wa110f48182003 wa110p96652002 wa33aa1 wc195o741997 wc750m7181993 ws135